Metabolites analysis of plantamajoside based on gut microbiota-drug interaction
Phytomedicine · 2023-07 · 116 · 154841
DOI: 10.1016/j.phymed.2023.154841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2023-07. Verfasst von Hui Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences/Peking Union Medical College, Beij…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Plantaginis Herba (Plantago asiatica L.) has the effects of clearing heat and diuresis, oozing wet and drenching. As the main active components of Plantaginis Herba (Plantago asiatica L.), plantamajoside have a wide range of antitumor activities but very low bioavailability. The process of interacting between plantamajoside and gut microbiota remains unclear. PURPOSE: To illustrate the process of interacting between plantamajoside and gut microbiota based on high-resolution mass spectrometry and targeted metabolomics methods. STUDY DESIGN AND METHODS: This experiment was divided into two parts. First, metabolites produced from plantamajoside by gut microbiota were identified and quantified based on high-resolution mass spectrometry and LC-MS/MS. Additionally, stimulation of plantamajoside on gut microbiota-derived metabolites was determined by targeted metabolomics and gas chromatography. RESULTS: We first found that plantamajoside was rapidly metabolized by gut microbiota. Then, we identified metabolites of plantamajoside by high-resolution mass spectrometry and speculated that plantamajoside was metabolized into five metabolites including calceolarioside A, dopaol glucoside, hydroxytyrosol, 3-(3-hydroxyphenyl) propionic acid (3-HPP) and caffeic acid. Among them, we quantitatively analyzed four possible metabolites based on LC‒MS/MS and found that hydroxytyrosol and 3-HPP were final products by the gut microbiota. In addition, we studied whether plantamajoside could affect the short-chain fatty acid (SCFA) and amino acid metabolites. We found that plantamajoside could inhibit the acetic acid, kynurenic acid (KYNA) and kynurenine (KN) produced by intestinal bacteria and promote the indole propionic acid (IPA) and indole formaldehyde (IALD) produced by intestinal bacteria. CONCLUSION: An interaction between plantamajoside and gut microbiota was revealed in this study. Unlike the traditional metabolic system, the special metabolic characteristics of plantamajoside in gut microbiota was found. Plantamajoside was metabolized into the following active metabolites: calceolarioside A, dopaol glucoside, hydroxytyrosol, caffeic acid and 3-HPP. Besides, plantamajoside could affect SCFA and tryptophan metabolism by gut microbiota. Especially, the exogenous metabolites hydroxytyrosol, caffeic acid and endogenous metabolites IPA may have potential association with the antitumor activity of plantamajoside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100050, China.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100050, China. Electronic address: jiang.jdong@163.com.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100050, China. Electronic address: wangyan@imm.ac.cn.
Zitieren
APA
Xu, H., Yu, H., Fu, J., Zhang, Z. W., Hu, J. C., Lu, J. Y., Yang, X. Y., Bu, M. M., Jiang, J. D., & Wang, Y. (2023). Metabolites analysis of plantamajoside based on gut microbiota-drug interaction. Phytomedicine, 116, 154841. https://doi.org/10.1016/j.phymed.2023.154841
Vancouver
Xu H, Yu H, Fu J, Zhang ZW, Hu JC, Lu JY, et al. Metabolites analysis of plantamajoside based on gut microbiota-drug interaction. Phytomedicine. 2023;116:154841. doi:10.1016/j.phymed.2023.154841
BibTeX
@article{Xu2023,
author = {Xu, Hui and Yu, Hang and Fu, Jie and Zhang, Zheng-Wei and Hu, Jia-Chun and Lu, Jin-Yue and Yang, Xin-Yu and Bu, Meng-Meng and Jiang, Jian-Dong and Wang, Yan},
title = {Metabolites analysis of plantamajoside based on gut microbiota-drug interaction},
journal = {Phytomedicine},
year = {2023},
volume = {116},
pages = {154841},
doi = {10.1016/j.phymed.2023.154841}
}
EUVIMED